Diabetes UK: Alcohol study not a “green light”
31 Jul 2017 --- A recent study in which researchers from Denmark suggest that drinking moderately three or four times a week may reduce the risk of diabetes shouldn’t be taken as a “green light” to drink to excess due to the “complex” nature of the disease, according to a Diabetes UK response. The study, published in Diabetologia, the journal of the European Association for the Study of Diabetes, outlines that people who drink three to four times per week are less likely to develop Type 2 diabetes than those who never drink. In response to the study, Dr. Emily Burns, Head of Research Communications at Diabetes UK, says: “Type 2 diabetes risk is complex. Several factors contribute to it, including family history, ethnic background, age and being overweight. While these findings are interesting, we wouldn’t recommend people see them as a green light to drink more than the existing NHS guidelines. Especially as the impact of regular alcohol consumption on the risk of Type 2 will be different from one person to the next.” “Type 2 diabetes is a serious condition, and around three in five cases can be prevented or delayed by eating healthily, moving more and losing weight if you’re overweight. If you’re worried about your risk of developing the condition, we’d advise you to speak to a healthcare professional,” Burns adds. Diabetes UK also calls the finding “very interesting” in its response but emphasizes that further research is needed as people may change their drinking habits over time, while researchers in the study recorded drinking habits only once. To better understand how alcohol might affect the risk of Type 2 diabetes, it says, future research would need to follow people for a longer period and record any changes in their alcohol intake. by Paul Creasy To contact our editorial team please email us at editorial@cnsmedia.com
Related ArticlesHealth & Nutrition News Family awareness highlighted during World Diabetes Day14 Nov 2018 --- Four in five parents have trouble recognizing the warning signs of diabetes, according to research by the International Diabetes Federation (IDF). To mark this year’s World Diabetes Day, IDF is seeking to raise awareness of the effect diabetes has on the family, with a particular focus on prevention and management of the disease. Health & Nutrition News Bone broth growth: Essentia taps healthier alternative trends with new organic beef bone broth powder14 Nov 2018 --- Trends toward high-protein, low carb foods are driving innovation at Essentia Protein Solutions which is tapping into the growing popularity of bone broth as part of its showcase during the forthcoming Food Matters Live, in London next week (20-22 November 2018). The company will be presenting a range of nutrient-rich applications including a new organic beef bone broth, a collagen peptide-based cordial drink and a high protein pork crunch snack. Health & Nutrition News Supplement use in China could ease the double burden of malnutrition, researchers note14 Nov 2018 --- Despite the Chinese population displaying deficiencies in some key nutrients, such as vitamin B2 and calcium, research has shown that the use of nutritional supplements is relatively low. The involved researchers suggest that adequate supplementation could help to ease the double burden of malnutrition facing the country. Health & Nutrition News Experts weigh in on digestive health in Kerry Health and Nutrition Institute webinar14 Nov 2018 --- Gut health is becoming increasingly popular among consumers. In this wide-ranging health area, the gut-brain axis (GBA) is a key area of interest, along with the sort of probiotic bacteria that aid wider gut health, Dairy & Food Culture Technologies Consultant, Dr. Mary Ellen Sanders, tells NutritionInsight. Sanders will be presenting a Kerry Health and Nutrition Institute webinar today hosted on FoodIngredientsFirst.com. Health & Nutrition News How vitamin D and fish oil reduce heart attack, stroke and cancer risk: Long-awaited VITAL study bears first results13 Nov 2018 --- Omega 3 fatty acids can aid in reducing the risk of heart attacks, especially among African Americans, while vitamin D can reduce cancer deaths over time. These are among the long-awaited findings of the VITamin D and OmegA-3 TriaL (VITAL) study. VITAL is the first randomized clinical trial of a general population large enough to adequately address questions surrounding the effects of vitamin D and omega 3 fatty acids derived from fish oil, in high doses, on the risk of diseases such as heart attack, stroke and cancer. More Articles |
.jpg)
